1
|
Fornicin D |
Antioxidant activity |
G. cochlear
|
[15] |
2
|
Cochlearin H |
Antioxidant activity |
G. cochlear
|
[30] |
3
|
Chizhine D |
Renoprotective effect |
G. lucidum
|
[31] |
4
|
Cochlearin G |
Antioxidant activity |
G. cochlear
|
[30] |
5
|
Applanatumol S |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
6
|
Applanatumol T |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
7
|
Ganomycin F |
Antioxidant activity |
G. capense
|
[15] |
8
|
Ganoleucin B |
Inhibitory activities against HMG-CoA reductase and α-glucosidase |
G. leucocontextum
|
[33] |
9
|
Ganomycin J |
Inhibitory activity against HMGs reductase (IC50: 30 μM), aldose reductase and α-glucosidase |
G. lucidum
|
[34] |
10
|
Ganomycin E |
DPPH radical scavenging activity |
G. capense
|
[16] |
11
|
Ganomycin C |
Antioxidant activity |
G. cochlear
|
[15] |
12
|
Cochlearin I |
DPPH radical scavenging |
G. cochlear
|
[30] |
13
|
Cochlearol D |
|
G. cochlear
|
[35] |
14
|
(+)-Applanatumol U |
Inhibitory activity against COX-1 and COX-2 |
G. applanatum
|
[32] |
15
|
(+)-Chizhine E |
Renoprotective effects |
G. lucidum
|
[31] |
16
|
(+)-Lucidulactone B |
|
G. lucidum
|
[36] |
17
|
(+)-Zizhine A |
Renoprotective effects |
G. sinense
|
[37] |
18
|
(+)-Ganoleucin C |
Inhibition against HMG-CoA reductase and a-glucosidase |
G. leucocontextum
|
[33] |
19
|
(+)-Chizhine F |
Renoprotective effects |
G. lucidum
|
[31] |
20
|
(+)-Zizhine B |
Renoprotective effects |
G. sinense
|
[37] |
21
|
(+)-Zizhine C |
Renoprotective effects |
G. sinense
|
[37] |
22
|
(+)-Zizhine D |
Renoprotective effects |
G. sinense
|
[37] |
23
|
(+)-Zizhine E |
Renoprotective effects |
G. sinense
|
[37] |
24
|
(+)-Zizhine F |
Renoprotective effects |
G. sinense
|
[37] |
25
|
(+)-Fornicin E |
Renoprotective effects |
G. cochlear
|
[16] |
26
|
Chizhine A |
Renoprotective effects |
G. lucidum
|
[31] |
27
|
Chizhine B |
Renoprotective effects |
G. lucidum
|
[31] |
28
|
Chizhine C |
Renoprotective effects |
G. lucidum
|
[31] |
29
|
(+)-Cochlearin B |
Antioxidant activity |
G. cochlear
|
[30] |
30
|
(±)-Cochlearin D |
Antioxidant activity |
G. cochlear
|
[30] |
31
|
(+)-Lingzhine E |
Neural stem cell proliferation |
G. lucidum
|
[38] |
32
|
(+)-Applanatumol P |
Inhibitory activity against COX-1 and COX-2 |
G. applanatum
|
[32] |
33
|
(+)-Applanatumol Q |
Inhibitory activity against COX-1 and COX-2 |
G. applanatum
|
[32] |
34
|
(+)-Applanatumol R |
Inhibitory activity against COX-1 and COX-2 |
G. applanatum
|
[32] |
35
|
(±)-Ganocapensin A |
Inhibitory activity against COX-1 and COX-2 |
G. capense
|
[16] |
36
|
Ganocapensin B |
Antioxidant activity |
G. capense
|
[16] |
37
|
(±)-Cochlearin E |
Antioxidant activity |
G. cochlear
|
[30] |
38
|
Cochelarin F |
Antioxidant activity |
G. cochlear
|
[30] |
39
|
Applanatumol Z1 |
Inhibitory activity against COX-1 and COX-2 |
G. applanatum
|
[32] |
40
|
Cochlearol C |
|
G. cochlear
|
[33] |